Phase IV randomized clinical study: Peginterferon alfa-2a with adefovir or entecavir pre-therapy for HBeAg-positive chronic hepatitis B

Chao Wei Hsu, Wei Wen Su, Chuan Mo Lee, Cheng Yuan Peng, Wan Long Chuang, Jia Horng Kao, Heng Cheng Chu, Yi Hsiang Huang, Rong Nan Chien*, Yun Fan Liaw

*Corresponding author for this work

Research output: Contribution to journalJournal Article peer-review

24 Scopus citations

Fingerprint

Dive into the research topics of 'Phase IV randomized clinical study: Peginterferon alfa-2a with adefovir or entecavir pre-therapy for HBeAg-positive chronic hepatitis B'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology